Uncategorized

by Rich Condit Rich Condit is a virologist and emeritus Professor, University of Florida, Gainesville and a host on This Week in Virology. Modeling done by the Institute for Health Metrics and Evaluation (IHME) at the University of Washington suggests that if stringent social distancing measures are kept in place, the €œfirst wave€ of covid-19 …

Infection Fatality Rate €“ A Critical Missing Piece for Managing Covid-19 Read More »

By David Tuller, DrPH My sweet friend Anil van der Zee lives in Amsterdam–more accurately, he lives on his bed in an apartment somewhere in Amsterdam. Like too many, he’s had a lot of experience at self-isolating. Below is part of the blog he posted a few days ago. ********** The Distant Corona Connection Adjusting. …

Trial By Error: Thoughts on Self-Isolation from Anil van der Zee Read More »

By David Tuller, DrPH I am slowly adjusting to the new realities and what they mean for life and work for at least the next couple of months; this lockdown or “sheltering-at-home” or whatever is likely to continue through most of May, if not longer. This is a marathon, not a sprint. Being largely homebound …

Trial By Error: A Long-Time Patient Reflects on a Stay-At-Home World Read More »

By David Tuller, DrPH It’s a frightening time for everyone. As we know, people with underlying medical conditions are at greater risk from coronavirus. At the same time, many of these individuals long ago adopted some of the strategies everyone is now being asked to adopt. Certainly people with ME–or with what is referred to …

Trial By Error: Some Coronavirus Advice from ME Association’s Dr Charles Shepherd Read More »

by Helen Stillwell Helen is a research associate in David Hafler€™s immunobiology lab at Yale University; previously, she worked on poxviruses at Tonix Pharmaceuticals, and she plans to apply to PhD programs in virology this year. RT-PCR Diagnostics As cases of COVID-19 continue to rise, diagnostic testing has been a principal topic of discussion. Typically, …

On COVID-19 Testing: How it Works, Shortages, and Innovation Read More »

Chloroquine (and a derivative, hydroxychloroquine) has been used for years in the treatment of malaria. The drug is also known to block the entry of many viruses into cells. A small clinical trial has revealed it to be effective in reducing viral loads in COVID-19 patients.